InsidersTradesSigma
Track the YIELD10 BIOSCIENCE, INC. share price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Food & Agriculture sector, YIELD10 BIOSCIENCE, INC. has published 57 public disclosures. The latest transaction was disclosed on 20 August 2024 (Retenue fiscale). Among the most active insiders: Sinskey Anthony J. The full history is free.
57
Insider Decl.
n/a
Thresholds
€1m
7 ops.
Buy Volume
€61,809
6 ops.
Sell Volume
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 August 2024
Declarations57 total
877 shares@ US$1.501.7% of flowCommon StockSEC:0001628280-24-037879:0
731 shares@ US$1.501.7% of flowCommon StockSEC:0001104659-24-090983:0
1,463 shares@ US$1.500.8% of flowCommon StockSEC:0001104659-24-090981:0
731 shares@ US$1.501.3% of flowCommon StockSEC:0001104659-24-090982:0
36,000 shares@ US$0.200.5% of flowCommon StockSEC:0000908834-24-000148:0
20,561 shares0Common StockSEC:0001628280-24-013920:0
11,924 shares0Common StockSEC:0001628280-24-013923:0
41,118 shares0Common StockSEC:0001628280-24-013917:0
120,000 shares@ US$0.3048.3% of flowCommon StockSEC:0001628280-24-005491:0
100,000 shares@ US$0.3037.0% of flowCommon StockSEC:0001104659-24-025035:0
100,000 shares@ US$0.3047.2% of flowCommon StockSEC:0001104659-24-025032:0
200,000 shares@ US$0.3023.2% of flowCommon StockSEC:0001104659-24-025033:0
18,879 shares0Common StockSEC:0001628280-24-000210:0
16,275 shares0Common StockSEC:0001628280-24-000206:0
16,275 shares0Common StockSEC:0001628280-24-000203:0
36,000 shares@ US$0.20640.5% of flowCommon StockSEC:0000908834-23-000190:0
35,000 shares@ US$0.23770.5% of flowCommon StockSEC:0000908834-23-000181:0
765,000 shares@ US$0.6532.0% of flowCommon StockSEC:0000908834-23-000120:0
Canonical exit: 13 Nov 2023 (T+90)
41,399 shares@ US$0.31080.9% of flowCommon StockSEC:0000908834-23-000118:0
11,955 shares0Common StockSEC:0001121702-23-000058:0
13,868 shares0Common StockSEC:0001121702-23-000056:0
11,955 shares0Common StockSEC:0001121702-23-000054:0
2,040 shares0Common StockSEC:0001628280-23-024201:0
1,759 shares0Common StockSEC:0001628280-23-024197:0
1,759 shares0Common StockSEC:0001628280-23-024199:0
25 of 57 declarations
关于 YIELD10 BIOSCIENCE, INC.
YIELD10 BIOSCIENCE, INC.（股票代码：YTEN）是一家美国农业生物科学公司，曾于纳斯达克资本市场上市，并于 2024 年 5 月退市；其普通股随后符合在 OTC 市场以 YTEN 符号报价的资格。对于投资者而言，这使得该公司处于农业生物技术领域的小盘、高风险部分，其估值严重依赖于知识产权、监管进展以及通过合作或许可而非大规模当前收入将技术商业化的能力。（[sec.gov](https://www.sec.gov/Archives/edgar/data/1121702/000110465924061645/tm2414256d2_ex99-1.htm?utm_source=openai)) 该公司可追溯到 1992 年，当时它以 Metabolix 的名义成立，拥有与麻省理工学院相关的许可背景。后来更名为 Yield10 Bioscience，以反映其向农业创新和作物产量提升的战略转变。Yield10 总部位于美国马萨诸塞州沃本，并通过其加拿大子公司 Yield10 Oilseeds Inc. 在萨斯喀彻温省萨斯卡通运营。（[sec.gov](https://www.sec.gov/Archives/edgar/data/1121702/000112170221000010/yten-20201231.htm?utm_source=openai)) Yield10 的核心业务围绕植物遗传学和通过其专有的“性状工厂”平台进行性状发现，以亚麻荠（Camelina sativa）作为主要作物平台。该公司致力于开发改良的亚麻荠品种和专有种子产品，旨在为可再生柴油和可持续航空燃料提供低碳原料油，为水产饲料、营养和制药应用提供 omega-3 油，以及长期来看，为可生物降解塑料提供 PHA 生物材料。它还寻求将与产量相关的性状许可给主要种子公司，用于玉米、大豆和油菜等作物。（[yield10bio.com](https://www.yield10bio.com/press/yield10-bioscience-announces-key-advancements-in-the-development-of-herbicide-tolerant-camelina-supporting-large-acreage-production-of-low-carbon-intensity-feedstock-oil-for-the-biofuel-market?utm_source=openai)) 从竞争角度来看，Yield10 占据了一个狭窄但可能具有吸引力的利基市场。它不是一个大面积农业投入的领导者；相反，它在遗传资产的质量、田间验证数据以及亚麻荠作为平台作物的商业潜力方面展开竞争。投资案例取决于成功地从研发转向商业化，获得必要的监管批准，并将科学里程碑转化为合作伙伴资助的商业化。（[yield10bio.com](https://www.yield10bio.com/press/yield10-winter-camelina-proprietary-varieties-show-tolerance-commonly-used-herbicides?utm_source=openai)) 最近的发展突显了机遇和财务压力。2024 年 7 月，Yield10 宣布与 Nuseed Nutritional US Inc. 签订了一份谅解备忘录和许可协议，涵盖与亚麻荠相关的某些 omega-3 知识产权、材料和专有技术，突显了其以伙伴关系为主导的战略。早期的更新还强调了耐除草剂亚麻荠、种子规模扩大和商业化途径工作。与此同时，2024 年纳斯达克退市标志着一个重要的负面事件，并表明该公司仍处于受限的融资环境中。（[sec.gov](https://www.sec.gov/Archives/edgar/data/1121702/000112170224000055/exhibit991-ytenx20240712xx.htm?utm_source=openai))
